Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

Doxorubicin 8Cisplatin 5Chemotherapy, Adjuvant 5Thalidomide 4Radiofrequency Ablation 4Neoadjuvant Therapy 4Melphalan 4Cyclophosphamide 4Carboplatin 4tremelimumab 3fludarabine 3aldesleukin 3Sorafenib 3Irinotecan 3Capecitabine 3durvalumab 2carotuximab 2Temozolomide 2Tamoxifen 2Oxaliplatin 2Leucovorin 2Gemcitabine 2Fluorouracil 2Fluorodeoxyglucose F18 2Epirubicin 2Cryosurgery 2Biopsy 2Bevacizumab 2sargramostim 1ropidoxuridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Liver Neoplasms × advexin × Clear all
NCT00003147 2013-02-05

Gene Therapy in Treating Patients With Cancer of The Liver

National Cancer Institute (NCI)

Phase 1 Terminated
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡